ARCHIVES

FDA Advisors Give Dox-SL Conditional Approval; Ok Zoladex

This article is from The Cancer Letter archive.

Vol. 21 No. 08 | February 24, 1995

Download PDF Visit The Full Archive

Related Articles

DOD Seeks to Fund Innovative Research In 438 Million Prostate Cancer Program

August 22, 1997

Groups Urge Passage of Health Care Reform Legislation

January 29, 2010

Five NCAB members complete terms.

February 20, 2004

Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects

April 30, 2010

Tobaccos Council Awards New Grants

April 3, 1981

DCE Publishes Lister of Resources Available To Scientific Community

November 9, 1984